Published 16 May 2023 As of 15:40 CEST 16th May 2023, our Housing Account and Application web page is out of service. From 25th May, the page is up again. It has been working for 5+ hours, but we are still monitoring the situation. 25th May 2023, 15:00 CEST The issue seems to have been resolved. We are continuing to monitor the situation. 25th May 2023, 10:45 CEST The housing portal is up again. T

https://www.luaccommodation.lu.se/article/housing-account-page-out-service-solved-25th-may - 2025-08-15

Published 1 December 2016 Using the CRISPR/Cas9 “gene scissors” researchers at Lund University Diabetes Centre in Sweden have managed to “turn off” an enzyme that proved to play a key role in the regulation of the diabetes-associated TXNIP gene. The results are decreased cell death and increased insulin production in the genetically modified pancreatic beta cells. In a recent study, researchers ha

https://www.ludc.lu.se/article/decreased-cell-death-and-increased-insulin-production-pancreatic-beta-cells-genome-edit-crisprcas9 - 2025-08-15

Published 14 December 2016 Charlotte Ling, professor of epigenetics at the Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden, has been awarded the European Research Council’s Consolidator Grant. The funding of EUR 2 million over five years will be used to develop new methods to improve prediction, prevention and treatment of type 2 diabetes. Charlotte Ling is a pion

https://www.ludc.lu.se/article/investments-epigenetics-combat-diabetes - 2025-08-15

Published 6 February 2017 BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-year

https://www.ludc.lu.se/article/beat-dkd-innovative-medicines-initiative-project-precision-medicine-dkd - 2025-08-15

Published 5 March 2019 In his research in zebrafish, Olov Andersson of Karolinska Institutet strives to generate insulin-producing cells and new treatment methods for diabetes. This has led to his selection as a recipient of the Leif C. Groop award for outstanding research, awarded by the Lund University Diabetes Centre and sponsored by Novo Nordisk Sweden. "It is a quick process to generate genet

https://www.ludc.lu.se/article/prize-awarded-research-zebrafish-could-lead-new-treatments-diabetes - 2025-08-15

Published 4 April 2019 A two-days seminar gathered some 70 researchers from the University of Bergen, the Institute for Molecular Medicine in Finland (FIMM) and Lund University Diabetes Centre. - We wanted to strengthen the bonds that already exist and in the future create a Nordic network of metabolic researchers, says Ola Hansson who organized the meeting. Kay Prüfer from Max-Planck Institute in

https://www.ludc.lu.se/article/nordic-network-metabolic-researchers - 2025-08-15

Published 5 April 2019 In Skåne, newborn babies can be screened for type 1 diabetes and celiac disease (gluten intolerance). To raise awareness about the screening we will be running an information campain on all commuter trains and busses in Skåne during week 15 and 19. Screening för typ 1-diabetes och celiaki Children found to be at risk are eligable to participate in our prevention studies POIn

https://www.ludc.lu.se/article/screening-t1d-and-celiac-disease - 2025-08-15

Published 15 April 2019 The 3rd Joint EASD Islet Study Group and Beta-Cell Workshop gathered experts in islet cell biology - mainly beta cells - ranging from development to function and with a focus on both type 1- and type 2-diabetes. Top from left: Jonathan Esguerra, Lena Eliasson, Elaine Cowan, Clair Lyons, Amaya Lopez and Hindrik Mulder. In the front: Alexander Hamilton and Malin Fex. This yea

https://www.ludc.lu.se/article/3rd-joint-easd-islet-study-group-and-beta-cell-workshop - 2025-08-15

Published 17 April 2019 In Skåne, newborn babies can be screened for type 1 diabetes and celiac disease (gluten intolerance). More than expected have been found to have an increased risk of developing these diseases, and about thirty children have already been recruited for research studies aimed at lowering this risk. The oral insulin is mixed with the food. Photo: Johan Bävman Large-scale screen

https://www.ludc.lu.se/article/screening-finds-children-high-risk-type-1-diabetes-and-celiac-disease - 2025-08-15

Published 18 April 2019 David Nicholls, professor emeritus of Mitochondrial Physiology at the Buck Institute in Novato, California and mentor at the Lund University Diabetes Centre, has become a member of the British Royal Society. The society’s fellows include many of the world’s most eminent scientists. “I feel immensely honoured!” says David Nicholls. David Nicholls knew from a very early age t

https://www.ludc.lu.se/article/diabetes-researcher-elected-british-royal-society - 2025-08-15

Published 23 April 2019 In the past decade, knowledge of how lifestyle affects our genes, a research field called epigenetics, has grown exponentially. Researchers at the Lund University Diabetes Centre have summarised the state of scientific knowledge within epigenetics linked to obesity and type 2 diabetes in a review article published in the scientific journal Cell Metabolism. The epigenome is

https://www.ludc.lu.se/article/how-lifestyle-affects-our-genes - 2025-08-15

Published 26 April 2019 Indian women are younger and leaner than Swedish women when they develop gestational diabetes, a new study from Lund University Diabetes Centre shows. The researchers also found a gene that increases the risk of gestational diabetes in Swedish women, but which, on the contrary, turned out to have a protective effect in Indian women. " The study show that personalized treatm

https://www.ludc.lu.se/article/gestational-diabetes-india-and-sweden - 2025-08-15

Published 3 May 2019 Helena Elding Larsson, senior physician and associate professor at Lund University, has been awarded 1,1 million SEK from Odd Fellow Orden Sweden. Helena Elding Larsson has been awarded a gift as support for a research project aiming to study if oral insulin given to children from 4-7 months of age to 3 years, with high genetic risk, can prevent the development of beta cell au

https://www.ludc.lu.se/article/ludc-researcher-awarded - 2025-08-15

Published 20 May 2019 We are now looking for a new grant manager! The grant manager has a central role in connecting different stakeholders in the environment and from this position be involved in designing diverse centre activities. The position is full-time and is limited to six months. Start as soon as possible. For more information about the position, and apply

https://www.ludc.lu.se/article/open-position-grant-manager - 2025-08-15

Published 24 May 2019 The company builder and patron Bo Hjelt has become honorary doctor at the Faculty of Medicine at Lund University. The doctoral conferment ceremony was held in Lund on May 24. Professor Henrik Clausen, Copenhagen University, and Bo Hjelt during the doctoral conferment ceremony. Photo: Katrin Ståhl Bo Hjelt (born 1935) was born and raised in Sweden. He studied economics in Gene

https://www.ludc.lu.se/article/bo-hjelt-honorary-doctor-lund-university - 2025-08-15

Published 4 June 2019 Register now for a free, full-day symposium in Gothenburg, Sweden, on 14 June, 2019, hosted by the Nordic Society for Human Genetics and Precision Medicine. This satellite meeting before the annual ESHG conference will feature the latest findings in discovery genetics from the Nordic countries, presented by the next wave of researchers from Denmark, Estonia, Finland, Iceland,

https://www.ludc.lu.se/article/nshg-register-now - 2025-08-15

Published 10 June 2019 Presented on June 9 at the 2019 American Diabetes Association’s 79th Scientific Sessions and published in the New England Journal of Medicine (nejm.org), findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study show a drug that targets the immune system can delay type 1 diabetes a median of 2 years in children and adults at high risk. “This is great news for millions

https://www.ludc.lu.se/article/immunotherapy-delays-type-1-diabetes-diagnosis-people-high-risk - 2025-08-15

Published 27 August 2019 The Swedish Society of Medicine has awarded post retirement professor Åke Lernmark at Lund University with the Oscar Medin Prize and SEK 25 000. Åke Lernmark started his research career in type 1 diabetes in the 1970s.He is responsible for the Swedish part of the TEDDY study and TrialNet, among others, in which he has studied why certain children develop type 1 diabetes wh

https://www.ludc.lu.se/article/ake-lernmark-awarded-his-epoch-making-contributions-children-type-1-diabetes - 2025-08-15

Published 29 August 2019 ´Digitalization for the benefit of the diabetes patient´ är namnet på en av de fyra så kallade ”Super Sessions”, seminarieserier, vid kommande NLSDays. Det är diabetesvården som ska belysas: hur digitalisering kan förbättra den och vad läkemedelsindustrin gör inom området. Läs artikeln på Medeons blogg

https://www.ludc.lu.se/article/nlsdays-medeon-och-ludc-ar-vardar-super-session-diabetes - 2025-08-15

Published 3 September 2019 The role of gut microbiota in disease and health has become one of today’s hottest fields of research. In her thesis, Louise Brunkwall, nutritionist and doctoral student at Lund University in Sweden, studied overweight, obesity and the importance of diet quality in relation to our gut microbiota.  The three risk factors behind obesity Obesity arises when the energy intak

https://www.ludc.lu.se/article/thesis-significance-diet-quality-gut-microbiota - 2025-08-15